Evidence map›Paper›PMID 22640729›Full record

ArticleMicrobial cell factories2012

Production of 2,3-butanediol in Saccharomyces cerevisiae by in silico aided metabolic engineering.

Chiam Yu Ng, Moo-Young Jung, Jinwon Lee, Min-Kyu Oh

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Microbial cell factories, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 161 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Chemical and Sensory Profile of Grape Distillates Aged inMolecules (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Snapshot of the Probiotic Potential ofFoods (Basel, Switzerland) · 2023
    Article
  7. Improved 2,3-Butanediol Production Rate of Metabolically EngineeredInternational journal of molecular sciences · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Brewing and biochemical characterization ofFood production, processing and nutrition · 2022
    Article
  16. Article
  17. Microbial production of advanced biofuels.Nature reviews. Microbiology · 2021
    Review
  18. Evaluation of 2,3-Butanediol Production from Red SeaweedJournal of microbiology and biotechnology · 2020
    Article
  19. Adaptive laboratory evolution for growth coupled microbial production.World journal of microbiology & biotechnology · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Chiam Yu NgDepartment of Chemical & Biological Engineering, Korea University, Seoul 136-701, Republic of Korea.
Moo-Young Jung
Jinwon Lee
Min-Kyu Oh
Korea University · KRSogang University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background2,3-Butanediol is a chemical compound of increasing interest due to its wide applications. It can be synthesized via mixed acid fermentation of pathogenic bacteria such as Enterobacter aerogenes and Klebsiella oxytoca. The non-pathogenic Saccharomyces cerevisiae possesses three different 2,3-butanediol biosynthetic pathways, but produces minute amount of 2,3-butanediol. Hence, we attempted to engineer S. cerevisiae strain to enhance 2,3-butanediol production.

resultsWe first identified gene deletion strategy by performing in silico genome-scale metabolic analysis. Based on the best in silico strategy, in which disruption of alcohol dehydrogenase (ADH) pathway is required, we then constructed gene deletion mutant strains and performed batch cultivation of the strains. Deletion of three ADH genes, ADH1, ADH3 and ADH5, increased 2,3-butanediol production by 55-fold under microaerobic condition. However, overproduction of glycerol was observed in this triple deletion strain. Additional rational design to reduce glycerol production by GPD2 deletion altered the carbon fluxes back to ethanol and significantly reduced 2,3-butanediol production. Deletion of ALD6 reduced acetate production in strains lacking major ADH isozymes, but it did not favor 2,3-butanediol production. Finally, we introduced 2,3-butanediol biosynthetic pathway from Bacillus subtilis and E. aerogenes to the engineered strain and successfully increased titer and yield. Highest 2,3-butanediol titer (2.29 . l-1) and yield (0.113 g . g-1) were achieved by Δadh1 Δadh3 Δadh5 strain under anaerobic condition.

conclusionsWith the aid of in silico metabolic engineering, we have successfully designed and constructed S. cerevisiae strains with improved 2,3-butanediol production.

Indexed as

Alcohol DehydrogenaseBacillus subtilisBacterial ProteinsBiosynthetic PathwaysButylene GlycolsGene DeletionMetabolic EngineeringSaccharomyces cerevisiae2,3-butylene glycolAlcohol DehydrogenaseBacterial ProteinsButylene Glycols

Identifiers

PMID22640729
PMCPMC3442981
OpenAlexW2131866875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.